This compound is a protected arginine derivative used as a building block in peptide synthesis. It features a sulfonyl-protecting group on the guanidino side chain, enabling controlled stepwise assembly of arginine-containing peptides in laboratory research and pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
FMOC-Arg(Pbf)-OH
pharmaceutical intermediate
N-Boc-N'-(4-methoxy-2,3,6-trimethylbenzenesulfonyl)-L-arginine
pharmaceutical intermediate
3-[2-Benzyloxycarbonylamino-3-(2-carboxy-ethoxy)-2-(2-carboxy-ethoxymethyl)-propoxy]-propionic acid
pharmaceutical intermediate
(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylic acid
pharmaceutical intermediate
1-Benzyl 2-methyl (2S)-4-methylidenepyrrolidine-1,2-dicarboxylate
pharmaceutical intermediate
6-chloro-9-(beta-D-ribofuranosyl)-9H-purin-2-amine
pharmaceutical intermediate
N-Boc-N'-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sufonyl)-L-arginine
pharmaceutical intermediate
N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(1,1-dimethylethoxy)carbonyl]-D-ornithine
pharmaceutical intermediate
(2S)-2-amino-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]pentanoic acid
GVIXTVCDNCXXSH-AWEZNQCLSA-N
CC1=C(C(=C(C2=C1OC(C2)(C)C)C)S(=O)(=O)NC(=NCCC[C@@H](C(=O)O)N)N)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.